Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
Inflammation, Cardiac Surgical Procedures

About this trial
This is an interventional treatment trial for Inflammation focused on measuring Intensive Care,Neonatal, Parenteral nutrition, Fat emulsions,Intravenous
Eligibility Criteria
Inclusion Criteria: 36 weeks gestation 3 months corrected age appropriate for gestational age (AGA) admitted for surgical correction of congenital heart defects (single ventricle, tetralogy of Fallot, truncus and complex biventricular repairs) enteral nutrition at 30 kcal/kilogram/day Exclusion Criteria: 5 minute Apgar score of 4 major congenital defect other than heart defect presence of significant neonatal morbidity (intraventricular hemorrhage (IVH) grade 3 or greater, necrotizing enterocolitis (NEC) and surgical abdomen) any metabolic disorder any endocrine disorder medications which alter eicosanoid metabolism including indomethacin, acetylsalicylate (with exception of steroids which will be analyzed independently)
Sites / Locations
- Stollery Children's Hospital